PDT Partners’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIK
TI
FWIA
PDT Partners's ANIK Position: Q1 2022 in Review
PDT Partners sold out of Anika Therapeutics (ANIK) in Q1 2022, closing a stake of 8,128 shares — an estimated $291K sold.
PDT Partners first reported a position in ANIK in Q3 2013 and held it in 15 quarters. The position peaked at $1.51M in Q3 2013. 118 funds tracked by Wall St. Rank hold ANIK as of Q1 2022.
- PDT Partners reported no remaining Anika Therapeutics position as of Q1 2022 after selling out during the quarter.
- PDT Partners sold 8,128 Anika Therapeutics shares in Q1 2022, an estimated $291K.
- PDT Partners first reported a position in Anika Therapeutics in Q3 2013 and held it in 15 quarters.
- PDT Partners's Anika Therapeutics position peaked at $1.51M in Q3 2013.
- 118 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2022.
Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.